Impaired insulin secretion and enhanced insulin sensitivity in cholecystokinin-deficient mice

Diabetes

Volumn 60, Issue 7, 2011, Pages 2000-2007

  Lo, Chun Min ^a,b   Obici, Silvana ^a,c   Dong, H Henry ^b   Haas, Michael ^c   Lou, Dawnwen ^b   Kim, Dae Hyun ^b   Liu, Min ^a,b   D'Alessio, David ^c   Woods, Stephen C ^a,b   Tso, Patrick ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CHOLECYSTOKININ; GLUCOSE; DIAGNOSTIC AGENT; INSULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; GENE DELETION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID DIET; LOW FAT DIET; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET CELL; PRIORITY JOURNAL; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FAT INTAKE; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; METABOLISM; MOUSE MUTANT; PANCREAS ISLET BETA CELL; PHYSIOLOGY; SECRETION;

ANIMALS; ARGININE; CHOLECYSTOKININ; DIET, FAT-RESTRICTED; DIETARY FATS; GLUCOSE; GLUCOSE INTOLERANCE; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MICE; MICE, KNOCKOUT;

EID: 80052101081     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0789     Document Type: Article

References (39)

1. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106: 473-481 (Pubitemid 30666380)
2. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 1985;75:1144-1152 (Pubitemid 15087139)
3. Hampton SM, Kwasowski P, Tan K, Morgan LM, Marks V. Effect of pretreatment with a high fat diet on the gastric inhibitory polypeptide and insulin responses to oral triolein and glucose in rats. Diabetologia 1983;24: 278-281 (Pubitemid 13118622)
4. Liddle RA, Goldfine ID, Williams JA. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology 1984; 87:542-549 (Pubitemid 14061405)
5. Reimer MK, Holst JJ, Ahrén B. Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice. Eur J Endocrinol 2002;146:717-727 (Pubitemid 34552507)
6. Nauck MA, Meier JJ. Incretins and regulation of insulin secretion. In Pancratic Beta Cell in Health and Disease. Seino S, Bell GI, Eds. Tokyo, Japan, Springer, 2008, p. 335-377
7. Stein LJ, Woods SC. Cholecystokinin and bombesin act independently to decrease food intake in the rat. Peptides 1981;2:431-436 (Pubitemid 12145751)
8. Raybould HE, Meyer JH, Tabrizi Y, Liddle RA, Tso P. Inhibition of gastric emptying in response to intestinal lipid is dependent on chylomicron formation. Am J Physiol 1998;274:R1834-R1838
9. Frame CM, Davidson MB, Sturdevant RA. Effects of the octapeptide of cholecystokinin on insulin and glucagon secretion in the dog. Endocrinology 1975;97:549-553
10. Sakamoto C, Otsuki M, Ohki A, et al. Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas. Endocrinology 1982;110:398-402 (Pubitemid 12162928)
11. Ahrén B, Hedner P, Lundquist I. Interaction of gastric inhibitory polypeptide (Gintraperitoneal) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice. Acta Endocrinol (Copenh) 1983;102: 96-102 (Pubitemid 13169479)
12. Verspohl EJ, Ammon HP, Williams JA, Goldfine ID. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans. Diabetes 1986;35:38-43 (Pubitemid 16162825)
13. Karlsson S, Ahrén B. CCK-8-stimulated insulin secretion in vivo is mediated by CCKA receptors. Eur J Pharmacol 1992;213:145-146
14. Niederau C, Schwarzendrube J, Lüthen R, Niederau M, Strohmeyer G, Rovati L. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers. Pancreas 1992;7:1-10
15. Rushakoff RA, Goldfine ID, Beccaria LJ, Mathur A, Brand RJ, Liddle RA. Reduced postprandial cholecystokinin (CCK) secretion in patients with noninsulin-dependent diabetes mellitus: evidence for a role for CCK in regulating postprandial hyperglycemia. J Clin Endocrinol Metab 1993;76: 489-493 (Pubitemid 23073079)
16. Ahrén B, Holst JJ, Efendic S. Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes. J Clin Endocrinol Metab 2000;85:1043-1048 (Pubitemid 32269347)
17. Rushakoff RJ, Goldfine ID, Carter JD, Liddle RA. Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans. J Clin Endocrinol Metab 1987;65:395-401 (Pubitemid 17135160)
18. Lacourse KA, Swanberg LJ, Gillespie PJ, Rehfeld JF, Saunders TL, Samuelson LC. Pancreatic function in CCK-deficient mice: adaptation to dietary protein does not require CCK. Am J Physiol 1999;276:G1302-G1309 (Pubitemid 29251930)
19. Woods SC, Seeley RJ, Rushing PA, D'Alessio D, Tso P. A controlled highfat diet induces an obese syndrome in rats. J Nutr 2003;133:1081-1087 (Pubitemid 36407129)
20. Taicher GZ, Tinsley FC, Reiderman A, Heiman ML. Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Anal Bioanal Chem 2003;377:990-1002 (Pubitemid 40877830)
21. Su D, Zhang N, He J, et al. Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis. Diabetes 2007;56:2274-2283 (Pubitemid 47358234)
22. Banerjee RR, Rangwala SM, Shapiro JS, et al. Regulation of fasted blood glucose by resistin. Science 2004;303:1195-1198 (Pubitemid 38233585)
23. Inzucchi SE. Classification and diagnosis of diabetes mellitus. In Ellenberg & Rifkin's Diabetes Mellitus. Porte D Jr, Sherwin RS, Baron A, Eds. New York, McGraw-Hill Companies, Inc., 2003, p. 265-275
24. Lo CM, Samuelson LC, Chambers JB, et al. Characterization of mice lacking the gene for cholecystokinin. Am J Physiol Regul Integr Comp Physiol 2008;294:R803-R810 (Pubitemid 351346956)
25. Szecówka J, Lins PE, Efendi? S. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats. Endocrinology 1982;110:1268-1272
26. Tachibana I, Akiyama T, Kanagawa K, et al. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats. Am J Physiol 1996;270:G730-G737
27. Sakamoto C, Goldfine ID, Roach E, Williams JA. Localization of saturable CCK binding sites in rat pancreatic islets by light and electron microscope autoradiography. Diabetes 1985;34:390-394 (Pubitemid 15143722)
28. Rossetti L, Shulman GI, Zawalich WS. Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific inhibitor of CCK-receptor binding. Diabetes 1987;36: 1212-1215
29. Leahy JL. Pathogenesis of type 2 diabetes mellitus. In Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical Management. Feinglos MN, Bethel MA, Eds. Totowa, NJ, Humana Press, 2008, p. 17-33
30. Lo CM, King A, Samuelson LC, et al. Cholecystokinin knockout mice are resistant to high-fat diet-induced obesity. Gastroenterology 2010;138:1997-2005
31. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997;389:374-377 (Pubitemid 27415217)
32. Buse JB, Polonsky KS, Burant CF. Type 2 diabetes mellitus. In Williams Textbook of Endocrinology. Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, Eds. Philadelphia, PA, Saunders Elsevier, 2008, p. 1329-1389
33. Lewis LD, Williams JA. Regulation of cholecystokinin secretion by food, hormones, and neural pathways in the rat. Am J Physiol 1990;258:G512-G518 (Pubitemid 20144069)
34. Straathof JW, Adamse M, Onkenhout W, Lamers CB, Masclee AA. Effect of L-arginine on lower oesophageal sphincter motility in man. Eur J Gastroenterol Hepatol 2000;12:419-424 (Pubitemid 30218947)
35. Spannagel AW, Nakano I, Tawil T, Chey WY, Liddle RA, Green GM. Adaptation to fat markedly increases pancreatic secretory response to intraduodenal fat in rats. Am J Physiol 1996;270:G128-G135
36. Little TJ, Feltrin KL, Horowitz M, et al. A high-fat diet raises fasting plasma CCK but does not affect upper gut motility, PYY, and ghrelin, or energy intake during CCK-8 infusion in lean men. Am J Physiol Regul Integr Comp Physiol 2008;294:R45-R51
37. Peitl B, Döbrönte R, Drimba L, et al. Involvement of cholecystokinin in baseline and post-prandial whole body insulin sensitivity in rats. Eur J Pharmacol 2010;644:251-256
38. Cheung GW, Kokorovic A, Lam CK, Chari M, Lam TK. Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab 2009;10:99-109
39. Obici S, Martins PJ. The role of brain. In Glucose Metabolism in Principle of Diabetes Mellitus. Poretsky L, Ed. New York, Springer, 2010, p. 89-104